Drug Ministry moves to cancel license of Coretox and Meditoxin 200 unit for illegally trading in China After most of its Meditoxin units were stripped of its sales licenses, Medytox is at risk of ...

On May 12, Medytox announced its consolidated results for the first quarter of this year, reporting sales of KRW 60.7 billion, operating profit of KRW 7.4 billion, and net profit of KRW 7.9 billion.

The biopharmaceutical company Medytox announced on the 12th that its consolidated revenue in the first quarter was 64 billion won, an increase of 17% compared to the same period last year. The company ...

Medytox said on the 12th that it posted 60.7 billion won in consolidation sales in the first quarter of this year. That was down 5% from a year earlier. Operating profit was 7.4 billion won, and net ...